Tredje AP-fonden’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-25,038
Closed -$4.6M 278
2021
Q2
$4.6M Hold
25,038
0.09% 132
2021
Q1
$3.83M Hold
25,038
0.09% 143
2020
Q4
$3.91M Hold
25,038
0.1% 141
2020
Q3
$2.87M Hold
25,038
0.09% 134
2020
Q2
$2.81M Sell
25,038
-18,288
-42% -$2.05M 0.12% 127
2020
Q1
$3.89M Buy
43,326
+2,693
+7% +$242K 0.2% 101
2019
Q4
$4.39M Sell
40,633
-1,972
-5% -$213K 0.22% 116
2019
Q3
$4.17M Sell
42,605
-3,380
-7% -$331K 0.2% 132
2019
Q2
$6.02M Buy
45,985
+2,245
+5% +$294K 0.29% 77
2019
Q1
$5.91M Buy
43,740
+1,512
+4% +$204K 0.31% 77
2018
Q4
$4.11M Sell
42,228
-29,918
-41% -$2.91M 0.25% 97
2018
Q3
$10M Sell
72,146
-12,885
-15% -$1.79M 0.48% 48
2018
Q2
$10.6M Buy
85,031
+11,180
+15% +$1.39M 0.37% 76
2018
Q1
$8.23M Buy
73,851
+4,600
+7% +$513K 0.29% 87
2017
Q4
$8.28M Hold
69,251
0.28% 89
2017
Q3
$9.72M Buy
69,251
+1,075
+2% +$151K 0.34% 75
2017
Q2
$8.3M Hold
68,176
0.31% 75
2017
Q1
$8.27M Hold
68,176
0.33% 71
2016
Q4
$8.34M Sell
68,176
-1,200
-2% -$147K 0.35% 66
2016
Q3
$8.5M Sell
69,376
-2,711
-4% -$332K 0.38% 62
2016
Q2
$8.42M Sell
72,087
-2,627
-4% -$307K 0.38% 60
2016
Q1
$10.4M Buy
74,714
+6,281
+9% +$872K 0.47% 49
2015
Q4
$13.1M Sell
68,433
-35,805
-34% -$6.83M 0.84% 27
2015
Q3
$16.3M Buy
104,238
+58,453
+128% +$9.14M 1.59% 11
2015
Q2
$7.84M Buy
+45,785
New +$7.84M 0.63% 39